À propos de la propriété intellectuelle Formation en propriété intellectuelle Respect de la propriété intellectuelle Sensibilisation à la propriété intellectuelle La propriété intellectuelle pour… Propriété intellectuelle et… Propriété intellectuelle et… Information relative aux brevets et à la technologie Information en matière de marques Information en matière de dessins et modèles industriels Information en matière d’indications géographiques Information en matière de protection des obtentions végétales (UPOV) Lois, traités et jugements dans le domaine de la propriété intellectuelle Ressources relatives à la propriété intellectuelle Rapports sur la propriété intellectuelle Protection des brevets Protection des marques Protection des dessins et modèles industriels Protection des indications géographiques Protection des obtentions végétales (UPOV) Règlement extrajudiciaire des litiges Solutions opérationnelles à l’intention des offices de propriété intellectuelle Paiement de services de propriété intellectuelle Décisions et négociations Coopération en matière de développement Appui à l’innovation Partenariats public-privé Outils et services en matière d’intelligence artificielle L’Organisation Travailler avec nous Responsabilité Brevets Marques Dessins et modèles industriels Indications géographiques Droit d’auteur Secrets d’affaires Académie de l’OMPI Ateliers et séminaires Application des droits de propriété intellectuelle WIPO ALERT Sensibilisation Journée mondiale de la propriété intellectuelle Magazine de l’OMPI Études de cas et exemples de réussite Actualités dans le domaine de la propriété intellectuelle Prix de l’OMPI Entreprises Universités Peuples autochtones Instances judiciaires Ressources génétiques, savoirs traditionnels et expressions culturelles traditionnelles Économie Financement Actifs incorporels Égalité des genres Santé mondiale Changement climatique Politique en matière de concurrence Objectifs de développement durable Technologies de pointe Applications mobiles Sport Tourisme PATENTSCOPE Analyse de brevets Classification internationale des brevets Programme ARDI – Recherche pour l’innovation Programme ASPI – Information spécialisée en matière de brevets Base de données mondiale sur les marques Madrid Monitor Base de données Article 6ter Express Classification de Nice Classification de Vienne Base de données mondiale sur les dessins et modèles Bulletin des dessins et modèles internationaux Base de données Hague Express Classification de Locarno Base de données Lisbon Express Base de données mondiale sur les marques relative aux indications géographiques Base de données PLUTO sur les variétés végétales Base de données GENIE Traités administrés par l’OMPI WIPO Lex – lois, traités et jugements en matière de propriété intellectuelle Normes de l’OMPI Statistiques de propriété intellectuelle WIPO Pearl (Terminologie) Publications de l’OMPI Profils nationaux Centre de connaissances de l’OMPI Série de rapports de l’OMPI consacrés aux tendances technologiques Indice mondial de l’innovation Rapport sur la propriété intellectuelle dans le monde PCT – Le système international des brevets ePCT Budapest – Le système international de dépôt des micro-organismes Madrid – Le système international des marques eMadrid Article 6ter (armoiries, drapeaux, emblèmes nationaux) La Haye – Le système international des dessins et modèles industriels eHague Lisbonne – Le système d’enregistrement international des indications géographiques eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Médiation Arbitrage Procédure d’expertise Litiges relatifs aux noms de domaine Accès centralisé aux résultats de la recherche et de l’examen (WIPO CASE) Service d’accès numérique aux documents de priorité (DAS) WIPO Pay Compte courant auprès de l’OMPI Assemblées de l’OMPI Comités permanents Calendrier des réunions WIPO Webcast Documents officiels de l’OMPI Plan d’action de l’OMPI pour le développement Assistance technique Institutions de formation en matière de propriété intellectuelle Mesures d’appui concernant la COVID-19 Stratégies nationales de propriété intellectuelle Assistance en matière d’élaboration des politiques et de formulation de la législation Pôle de coopération Centres d’appui à la technologie et à l’innovation (CATI) Transfert de technologie Programme d’aide aux inventeurs WIPO GREEN Initiative PAT-INFORMED de l’OMPI Consortium pour des livres accessibles L’OMPI pour les créateurs WIPO Translate Speech-to-Text Assistant de classification États membres Observateurs Directeur général Activités par unité administrative Bureaux extérieurs Avis de vacance d’emploi Achats Résultats et budget Rapports financiers Audit et supervision
Arabic English Spanish French Russian Chinese
Lois Traités Jugements Recherche par ressort juridique

Décret sur la protection juridique des inventions biotechnologiques, Slovénie

Retour
Version la plus récente dans WIPO Lex
Détails Détails Année de version 2003 Dates Entrée en vigueur: 2 septembre 2003 Type de texte Textes règlementaires Sujet Brevets (Inventions)

Documents disponibles

Texte(s) principal(aux) Textes connexe(s)
Texte(s) princip(al)(aux) Texte(s) princip(al)(aux) Anglais Decree on the Legal Protection of Biotechnological Inventions        
 SI034: Patents, Legal Protection of Biotechnological Inventions

On the basis of the second paragraph of Article 10 of the Industrial Property Act (Official

Gazette of the Republic of Slovenia, No. 7/03), the Government of the Republic of Slovenia

hereby issues the following

DECREE 1

ON THE LEGAL PROTECTION OF BIOTECHNOLOGICAL INVENTIONS

Article 1

This Decree defines detailed conditions for the grant of patents for biotechnological

inventions, which have to be fulfilled beside those prescribed by the Industrial Property Act.

Article 2

(1) For the purposes of this Decree,

(a) “biological material” means any material containing genetic information and capable of

reproducing itself or being reproduced in a biological system;

(b) “microbiological process” means any process involving or performed upon or resulting in

microbiological material.

(2) A process for the production of plants or animals is essentially biological if it consists

entirely of natural phenomena such as crossing or selection.

(3) “Variety” shall be taken to mean a plant grouping within a single botanical taxon of the

lowest known rank, which grouping, irrespective of whether the conditions for the grant of a

plant variety right are fully met, can be:

(a) defined by the expression of the characteristics that results from a given genotype or

combination of genotypes,

(b) distinguished from any other plant grouping by the expression of at least one of the said

characteristics, and

(c) considered as a unit with regard to its suitability for being propagated unchanged.

Article 3

(1) For the purposes of this Decree, inventions which are new, which involve an inventive

step and which are susceptible of industrial application shall be patentable even if they

concern a product consisting of or containing biological material or a process by means of

which biological material is produced, processed or used.

1 Published in the Official Gazette RS, No. 81/03. Entry into force: 2 September 2003.

(2) Biological material which is isolated from its natural environment or produced by means

of a technical process may be the subject of an invention even if it previously occurred in

nature.

Article 4

(1) The following shall not be patentable:

(a) plant and animal varieties; and

(b) essentially biological processes for the production of plants or animals.

(2) Inventions which concern plants or animals shall be patentable if the technical feasibility

of the invention is not confined to a particular plant or animal variety.

(3) Paragraph 1(b) shall be without prejudice to the patentability of inventions which concern

a microbiological or other technical process or a product obtained by means of such a process.

Article 5

(1) The human body, at the various stages of its formation and development, and the simple

discovery of one of its elements, including the sequence or partial sequence of a gene, cannot

constitute patentable inventions.

(2) An element isolated from the human body or otherwise produced by means of a technical

process, including the sequence or partial sequence of a gene, may constitute a patentable

invention, even if the structure of that element is identical to that of a natural element.

(3) The industrial application of a sequence or a partial sequence of a gene must be disclosed

in the patent application.

Article 6

(1) Inventions shall be considered unpatentable where their commercial exploitation would be

contrary to ordre public or morality; however, exploitation shall not be deemed to be so

contrary merely because it is prohibited by law or regulation.

(2) On the basis of paragraph 1, the following, in particular, shall be considered unpatentable:

(a) processes for cloning human beings;

(b) processes for modifying the germ line genetic identity of human beings;

(c) uses of human embryos for industrial or commercial purposes;

(d) processes for modifying the genetic identity of animals which are likely to cause them

suffering without any substantial medical benefit to man or animal, and also animals resulting

from such processes.

Article 7

(1) The protection conferred by a patent on a biological material possessing specific

characteristics as a result of the invention shall extend to any biological material derived from

that biological material through propagation or multiplication in an identical or divergent

form and possessing those same characteristics.

(2) The protection conferred by a patent on a process that enables a biological material to be

produced possessing specific characteristics as a result of the invention shall extend to

biological material directly obtained through that process and to any other biological material

derived from the directly obtained biological material through propagation or multiplication in

an identical or divergent form and possessing those same characteristics.

Article 8

The protection conferred by a patent on a product containing or consisting of genetic

information shall extend to all material, save as provided in Article 5(1), in which the product

in incorporated and in which the genetic information is contained and performs its function.

Article 9

The protection referred to in Articles 7 and 8 shall not extend to biological material obtained

from the propagation or multiplication of biological material placed on the market in the

territory of the Republic of Slovenia by the holder of the patent or with his consent, where the

multiplication or propagation necessarily results from the application for which the biological

material was marketed, provided that the material obtained is not subsequently used for other

propagation or multiplication.

Article 10

(1) By way of derogation from Articles 7 and 8, the sale or other form of commercialisation

of plant propagating material to a farmer by the holder of the patent or with his consent for

agricultural use implies authorisation for the farmer to use the product of his harvest,

according to Article 16 of the Protection of New Plant Varieties Act, for propagation or

multiplication by him on his own farm.

(2) By way of derogation from Articles 7 and 8, the sale or any other form of

commercialisation of breeding stock or other animal reproductive material to a farmer by the

holder of the patent or with his consent implies authorisation for the farmer to use the

protected livestock for an agricultural purpose. This includes making the animal or other

animal reproductive material available for the purposes of pursuing his agricultural activity

but not sale within the framework or for the purpose of a commercial reproduction activity.

Article 11

(1) Where a breeder cannot acquire or exploit a plant variety right without infringing a prior

patent, he may apply for a compulsory licence for non-exclusive use of the invention

protected by the patent inasmuch as the licence is necessary for the exploitation of the plant

variety to be protected, subject to payment of an appropriate royalty.

(2) Where the holder of a patent concerning a biotechnological invention cannot exploit it

without infringing a prior plant variety right, he may apply for a compulsory licence for non-

exclusive use of the plant variety protected by that right, subject to payment of an appropriate

royalty.

(3) Applicants for the licences referred to in paragraphs 1 and 2 must demonstrate that:

(a) they have applied unsuccessfully to the holder of the patent or of the plant variety right to

obtain a contractual licence;

(b) the plant variety or the invention constitutes significant technical progress of considerable

economic interest compared with the invention claimed in the patent or the protected plant

variety.

Article 12

Applications for patents for biotechnological inventions which were filed before the date of

entry into force of this Decree shall be treated in accordance with the provisions of this

Decree.

Article 13

This Decree shall enter into force on the fifteenth day following its publication in the Official

Gazette of the Republic of Slovenia.


Aucune donnée disponible

N° WIPO Lex SI034